全文获取类型
收费全文 | 1612篇 |
免费 | 142篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 63篇 |
妇产科学 | 43篇 |
基础医学 | 312篇 |
口腔科学 | 31篇 |
临床医学 | 146篇 |
内科学 | 267篇 |
皮肤病学 | 15篇 |
神经病学 | 355篇 |
特种医学 | 63篇 |
外科学 | 89篇 |
综合类 | 17篇 |
一般理论 | 2篇 |
预防医学 | 96篇 |
眼科学 | 7篇 |
药学 | 163篇 |
1篇 | |
肿瘤学 | 47篇 |
出版年
2016年 | 23篇 |
2015年 | 30篇 |
2014年 | 33篇 |
2013年 | 35篇 |
2012年 | 43篇 |
2011年 | 59篇 |
2010年 | 50篇 |
2009年 | 28篇 |
2008年 | 41篇 |
2007年 | 47篇 |
2006年 | 37篇 |
2005年 | 42篇 |
2004年 | 42篇 |
2003年 | 29篇 |
2002年 | 43篇 |
2001年 | 35篇 |
2000年 | 38篇 |
1999年 | 29篇 |
1998年 | 35篇 |
1997年 | 28篇 |
1996年 | 42篇 |
1995年 | 27篇 |
1994年 | 34篇 |
1993年 | 30篇 |
1992年 | 24篇 |
1991年 | 17篇 |
1990年 | 37篇 |
1989年 | 27篇 |
1988年 | 38篇 |
1987年 | 46篇 |
1986年 | 33篇 |
1985年 | 43篇 |
1984年 | 35篇 |
1983年 | 36篇 |
1982年 | 34篇 |
1981年 | 30篇 |
1980年 | 30篇 |
1979年 | 43篇 |
1978年 | 30篇 |
1977年 | 35篇 |
1976年 | 33篇 |
1975年 | 33篇 |
1974年 | 30篇 |
1973年 | 36篇 |
1972年 | 35篇 |
1971年 | 24篇 |
1970年 | 20篇 |
1968年 | 20篇 |
1967年 | 14篇 |
1966年 | 14篇 |
排序方式: 共有1758条查询结果,搜索用时 15 毫秒
51.
Camila Santos PEREIRA Marcos Vinícius Macedo de OLIVEIRA Lucas Oliveira BARROS Gabriela Alencar BANDEIRA Sérgio Henrique Sousa SANTOS John R. BASILE André Luiz Sena GUIMAR?ES Alfredo Maurício Batista DE PAULA 《Journal of applied oral science : revista FOB》2013,21(5):416-421
Objective
This study aimed to investigate the expression of the MSH2 DNA repair protein in head and neck squamous cell carcinoma (HNSCC) in order to analyze its association with clinicopathologic factors and overall survival of patients.Material and Methods
Clinical data and primary lesions of HNSSC were collected from 55 patients who underwent surgical resection with postoperative radiotherapy in Montes Claros, state of Minas Gerais, Brazil, between 2000 and 2008. Immunohistochemical reactions were performed to analyze MSH2 protein expression.Results
Bivariate analysis showed no significant correlation or association between MSH2 expression and clinicopathologic parameters by Mann-Whitney and Kruskal-Wallis tests. Patients with locoregional metastatic disease (OR=4.949, p<0.001) and lower MSH2 immunohistochemical expressions (OR=2.943, p=0.032) presented poorer survival for HNSCC by Cox regression models.Conclusions
Our data demonstrated that lower MSH2 expression might contribute to a higher clinic aggressiveness of HNSCC by promoting an unfavorable outcome. 相似文献52.
53.
Stephen H. Dinwiddie Jinger Hoop Elliot S. Gershon 《International review of psychiatry (Abingdon, England)》2013,25(4):320-328
Ethical issues in the use of genetic information
Published online:
11 July 2009Table 相似文献
54.
Gershon AA Arvin AM Shapiro E 《The New England journal of medicine》2007,356(25):2648-9; author reply 2648-9
55.
Eric M Gershon Leonel Rodriguez Ricardo A Arbizu 《World Journal of Clinical Pediatrics》2023,12(3):68-76
Hirschsprung’s disease (HSCR) is a congenital disorder characterized by failure of the neural crest cells to migrate and populate the distal bowel during gestation affecting different lengths of intestine leading to a distal functional obstruction. Surgical treatment is needed to correct HSCR once the diagnosis is confirmed by demonstrating the absence of ganglion cells or aganglionosis of the affected bowel segment. Hirschsprung’s disease associated enterocolitis (HAEC) is an inflammatory complication associated with HSCR that can present either in the pre- or postoperative period and associated with increased morbidity and mortality. The pathogenesis of HAEC remains poorly understood, but intestinal dysmotility, dysbiosis and impaired mucosal defense and intestinal barrier function appear to play a significant role. There is no clear definition for HAEC, but the diagnosis is primarily clinical, and treatment is guided based on severity. Here, we aim to provide a comprehensive review of the clinical presentation, etiology, pathophysiology, and current therapeutic options for HAEC. 相似文献
56.
Kenneth ES Poole Graham M Treece Rose A Pearson Andrew H Gee Michael A Bolognese Jacques P Brown Stefan Goemaere Andreas Grauer David A Hanley Carlos Mautalen Chris Recknor Yu-Ching Yang Maria Rojeski Cesar Libanati Tristan Whitmarsh 《Journal of bone and mineral research》2022,37(2):256-264
Romosozumab monoclonal antibody treatment works by binding sclerostin and causing rapid stimulation of bone formation while decreasing bone resorption. The location and local magnitude of vertebral bone accrual by romosozumab and how it compares to teriparatide remains to be investigated. Here we analyzed the data from a study collecting lumbar computed tomography (CT) spine scans at enrollment and 12 months post-treatment with romosozumab (210 mg sc monthly, n = 17), open-label daily teriparatide (20 μg sc, n = 19), or placebo (sc monthly, n = 20). For each of the 56 women, cortical thickness (Ct.Th), endocortical thickness (Ec.Th), cortical bone mineral density (Ct.bone mineral density (BMD)), cancellous BMD (Cn.BMD), and cortical mass surface density (CMSD) were measured across the first lumbar vertebral surface. In addition, color maps of the changes in the lumbar vertebrae structure were statistically analyzed and then visualized on the bone surface. At 12 months, romosozumab improved all parameters significantly over placebo and resulted in a mean vertebral Ct.Th increase of 10.3% versus 4.3% for teriparatide, an Ec.Th increase of 137.6% versus 47.5% for teriparatide, a Ct.BMD increase of 2.1% versus a −0.1% decrease for teriparatide, and a CMSD increase of 12.4% versus 3.8% for teriparatide. For all these measurements, the differences between romosozumab and teriparatide were statistically significant (p < 0.05). There was no significant difference between the romosozumab-associated Cn.BMD gains of 22.2% versus 18.1% for teriparatide, but both were significantly greater compared with the change in the placebo group (−4.6%, p < 0.05). Cortical maps showed the topographical locations of the increase in bone in fracture-prone areas of the vertebral shell, walls, and endplates. This study confirms widespread vertebral bone accrual with romosozumab or teriparatide treatment and provides new insights into how the rapid prevention of vertebral fractures is achieved in women with osteoporosis using these anabolic agents. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). 相似文献
57.
58.
Leah H. Rubin C. Sue Carter Jeffrey R. Bishop Hossein Pournajafi-Nazarloo Lauren L. Drogos S. Kristian Hill Anthony C. Ruocco Sarah K. Keedy James L. Reilly Matcheri S. Keshavan Godfrey D. Pearlson Carol A. Tamminga Elliot S. Gershon John A. Sweeney 《Schizophrenia bulletin》2014,40(6):1374-1384
Oxytocin (OT) and arginine vasopressin (AVP) exert robust influence on social affiliation and specific cognitive processes in healthy individuals. Abnormalities in these neuroendocrine systems have been observed in psychotic disorders, but their relation to impairments in behavioral domains that these endocrines modulate is not well understood. We compared abnormalities of OT and AVP serum concentrations in probands with schizophrenia (n = 57), schizoaffective disorder (n = 34), and psychotic bipolar disorder (n = 75); their first-degree relatives without a history of psychosis (n = 61, 43, 91, respectively); and healthy controls (n = 66) and examined their association with emotion processing and cognition. AVP levels were lower in schizophrenia (P = .002) and bipolar probands (P = .03) and in relatives of schizophrenia probands (P = .002) compared with controls. OT levels did not differ between groups. Familiality estimates were robust for OT (h
2 = 0.79, P = 3.97e−15) and AVP (h
2 = 0.78, P = 3.93e−11). Higher levels of OT were associated with better emotion recognition (β = 0.40, P < .001) and general neuropsychological function (β = 0.26, P = .04) in healthy controls as expected but not in any proband or relative group. In schizophrenia, higher OT levels were related to greater positive symptom severity. The dissociation of OT levels and behavioral function in all proband and relative groups suggests that risk and illness factors associated with psychotic disorders are not related to reduced OT levels but to a disruption in the ability of physiological levels of OT to modulate social cognition and neuropsychological function. Decreased AVP levels may be a marker of biological vulnerability in schizophrenia because alterations were seen in probands and relatives, and familiality was high.Key words: oxytocin, vasopressin, schizophrenia, bipolar disorder, emotion recognition 相似文献
59.
Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection 总被引:2,自引:0,他引:2
Novales JS; Salva AM; Modanlou HD; Kaplan DL; del Castillo J; Andersen J; Medlock ES 《Blood》1993,81(4):923-927
Maternally administered recombinant human granulocyte colony- stimulating factor (rhG-CSF) has been shown to cross the placenta and induce a peripheral neutrophilia and increases in the marrow and spleen neutrophil storage pools in fetal and newborn rats. In the present study, we have used this model system to investigate the efficacy of prenatally administered rhG-CSF on neonatal defense to a lethal challenge with Group B-beta hemolytic Streptococcus (GBS). Pregnant rats were injected with rhG-CSF twice daily beginning 6 days before parturition. At birth, all pups were infected with a dose of GBS that is lethal for 90% of infected pups (LD90). Survival was monitored daily for 5 days. Survival of infected pups from saline-treated mothers beyond 60 hours after infection was 10%. No difference in survival was observed among pups from mothers treated 2 and 4 days before parturition. In contrast, we determined that survival was 82.5% among infected pups from mothers treated for 6 days before parturition with rhG-CSF. Our results demonstrate that maternal administration of rhG- CSF augments neonatal defenses against a lethal bacterial challenge. 相似文献
60.
Use of anti-idiotype immunosorbents to isolate circulating antigen-specific T cell-derived molecules from hyperimmune sera. 总被引:4,自引:0,他引:4 下载免费PDF全文
G M Iverson D D Eardley C A Janeway R K Gershon 《Proceedings of the National Academy of Sciences of the United States of America》1983,80(5):1435-1439
We immunized four different sheep with antigen-binding material found in the serum of BALB/c mice 4 days after primary immunization with sheep erythrocytes (SRBC). The resultant antibodies made by the sheep contained a specificity(ies) that appeared to react with a dominant idiotype present on SRBC-specific Lyt-2+ T cells. The antiserum made by the sheep markedly inhibited the formation of antigen-specific rosettes by SRBC educated T cells but did not inhibit T cells educated to other heterologous erythrocytes from forming crossreacting rosettes with SRBC or specific rosettes with the homologous erythrocytes. The "anti-Id serum" was depleted of all activity against known immunoglobulin isotypes and light chains and then was used to isolate antigen-binding molecules from mice that were hyperimmunized with SRBC. The ShId+ material so isolated could be divided into two main groups--one that expressed immunoglobulin determinants, and one that did not. The former represented 15-25% of the ShId+ protein isolated and comprised a minority of the anti-SRBC antibody in the anti-SRBC serum; the latter group of proteins bound sheep glycophorin specifically and expressed constant region determinants found on a number of other antigen-specific T cell factors. These experiments suggest that antigen-binding molecules made by T cells display much less heterogeneity than do antibodies and also show that the serum of hyperimmune mice contains significant amounts of T cell-derived antigen-specific immunoregulatory molecules. 相似文献